Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism TBK1 inhibitors(Serine/threonine-protein kinase TBK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Exo Therapeutics, Inc.Startup |
Active Organization Exo Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Aicardi-Goutieres Syndrome | Preclinical | US | Exo Therapeutics, Inc.Startup | 23 May 2023 |
Systemic Lupus Erythematosus | Preclinical | US | Exo Therapeutics, Inc.Startup | 23 May 2023 |